Argos Therapeutics Prices 5.63 Mln Shares IPO At $8/Shr - Quick Facts

(RTTNews) - Argos Therapeutics, Inc. (ARGS) said it has priced its initial public offering of 5.625 million common shares at a public offering price of $8.00 per share, before underwriting discounts. All shares in the offering are being sold by Argos. Further, the underwriters were given an option for 30 days to buy up to 843,750 additional common shares from Argos at the public offering price, less the underwriting discount. Argos' common stock has been approved for listing on the NASDAQ Global Market and may commence trading under the ticker symbol "ARGS" on February 7, 2014.

Piper Jaffray & Co., Stifel, Nicolaus & Company, Incorporated and JMP Securities LLC are acting as book-running managers for the offering. Needham & Company, LLC is acting as co-manager.